Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × FED × Doxycycline × Clear all

Phase

Phase EARLY_PHASE1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1 Dermatologic 1

Conditions

Lymphoma, T-Cell, Cutaneous 1

Interventions

Imiquimod 2 Docetaxel 2 Cryotherapy 2 Celecoxib 2 pembrolizumab 1 pasireotide 1 gadolinium ethoxybenzyl DTPA 1 enzalutamide 1 Topotecan 1 Tablets 1 Sildenafil Citrate 1 Pentoxifylline 1 Mass Screening 1 Ketoconazole 1 Itraconazole 1 Herpes Zoster Vaccine 1 Fecal Microbiota Transplantation 1 Exercise 1 Estramustine 1 Epirubicin 1 Endoscopy, Digestive System 1 Endoscopic Ultrasound-Guided Fine Needle Aspiration 1 Doxycycline 1 Biopsy, Large-Core Needle 1 Azacitidine 1 Androgen Antagonists 1 2-(3-(1-carboxy-5-((6-fluoropyridine-3-carbonyl)amino)pentyl)ureido)pentanedioic acid 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03116659 2019-08-13

CTCL Directed Therapy

James J. Peters Veterans Affairs Medical Center

Phase EARLY_PHASE1 Unknown

DermatologicLymphoid

Lymphoma, T-Cell, Cutaneous

Data powered by HemOnc (CC BY 4.0) Colophon ⚡